Downregulation of Angiotensin II Type 1 Receptor by Hydrophobic 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors in Vascular Smooth Muscle Cells
ToshihiroIchiki, KotaroTakeda, TomotakeTokunou, NaokoIino, KensukeEgashira, HiroakiShimokawa, KatsuyaHirano, HideoKanaide, AkiraTakeshita · Arteriosclerosis Thrombosis and Vascular Biology · 2001
Abstract— 3-Hydroxy-3-methylglutaryl coenzyme A (HMG CoA) reductase inhibitors, so-called statins, reduce the relative risk of a major coronary event by lowering the serum cholesterol level. In addition, statins may confer beneficial effects by cholesterol-lowering independent mechanisms, which are incompletely characterized. Because angiotensin II (Ang II) plays crucial roles in the pathogenesis of cardiovascular diseases, we examined the effect of statins on the expression of the Ang II type 1 receptor (AT1-R) in cultured vascular smooth muscle cells (VSMCs). Cerivastatin and fluvastatin reduced the AT1-R mRNA and the AT1-R protein levels; however, pravastatin lacked this effect. Cerivastatin and fluvastatin suppressed the AT1-R promoter activity measured by luciferase assay but did not affect AT1-R mRNA stability, suggesting that the suppression occurs at the transcriptional level. Coincubation of VSMCs with mevalonate or geranylgeranyl pyrophosphate but not with farnesyl pyrophosphate reversed the cer...